Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Treatment of Erectile Dysfunction I

ClinicalTrials.gov ID: NCT01037244

Public ClinicalTrials.gov record NCT01037244. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 2, 2026, 9:09 PM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Placebo-controlled, Double-Blind, Parallel Design, Phase 3 Study to Assess the Safety and Efficacy of Udenafil Tablets in Male Subjects With Erectile Dysfunction

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Randomized, placebo-controlled, double-blind, parallel design, Phase 3 study to evaluate the safety and efficacy of udenafil, an orally administered, potent and selective inhibitor of PDE-5 versus placebo for the treatment of subjects with erectile dysfunction (ED).

Study identification

NCT ID
NCT01037244
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Warner Chilcott
Industry
Enrollment
618 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
19 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2009 (Type not available)
Primary completion
Mar 2010 (Actual)
Completion
Mar 2010 (Actual)
Last update posted
Dec 22, 2011

2009 – 2010

United States locations

U.S. sites
36
U.S. states
18
U.S. cities
35
Facility City State ZIP Site status
Warner Chilcott Investigational Site Birmingham Alabama 35209 —
Warner Chilcott Investigational Site Homewood Alabama 35209 —
Warner Chilcott Investigational Site Mesa Arizona 85213 —
Warner Chilcott Investigational Site Phoenix Arizona 85023 —
Warner Chilcott Investigational Site Tucson Arizona 85741 —
Warner Chilcott Investigational Site Laguna Hills California 92653 —
Warner Chilcott Investigational Site Newport Beach California 92660 —
Warner Chilcott Investigational Site San Diego California 92103 —
Warner Chilcott Investigational Site Torrance California 90505 —
Warner Chilcott Investigational Site Denver Colorado 80211 —
Warner Chilcott Investigational Site Middlebury Connecticut 06762 —
Warner Chilcott Investigational Site New Britain Connecticut 06052 —
Warner Chilcott Investigational Site Waterbury Connecticut 06708 —
Warner Chilcott Investigational Site Clearwater Florida 33761 —
Warner Chilcott Investigational Site Miami Florida 33143 —
Warner Chilcott Investigational Site Ocala Florida 34474 —
Warner Chilcott Investigational Site Columbus Georgia 31904 —
Warner Chilcott Investigational Site Melrose Park Illinois 60160 —
Warner Chilcott Investigational Site Jeffersonville Indiana 47130 —
Warner Chilcott Investigational Site Omaha Nebraska 68114 —
Warner Chilcott Investigational Site Garden City New York 11530 —
Warner Chilcott Investigational Site New York New York 10016 —
Warner Chilcott Investigational Site Rochester New York 14609 —
Warner Chilcott Investigational Site Chapel Hill North Carolina 27514 —
Warner Chilcott Investigational Site Charlotte North Carolina 28226 —
Warner Chilcott Investigational Site Concord North Carolina 28025 —
Warner Chilcott Investigational Site Wilmington North Carolina 28401 —
Warner Chilcott Investigational Site Winston-Salem North Carolina 27103 —
Warner Chilcott Investigational Site Cincinnati Ohio 45212 —
Warner Chilcott Investigational Site Bala-Cynwyd Pennsylvania 19004 —
Warner Chilcott Investigational Site Mt. Pleasant South Carolina 29464 —
Warner Chilcott Investigational Site Myrtle Beach South Carolina 29572 —
Warner Chilcott Investigational Site Sugar Land Texas 77479 —
Warner Chilcott Investigational Site Salt Lake City Utah 84107 —
Warner Chilcott Investigational Site Spokane Washington 99204 —
Warner Chilcott Investigational Site Spokane Washington 99208 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01037244, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 22, 2011 · Synced Nov 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01037244 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →